Growth Opportunities in European Prenatal Genetic Testing Market - Forecast to 2021

  • ID: 4438675
  • Report
  • Region: Europe
  • 81 Pages
  • Frost & Sullivan
1 of 4
Non-invasive Prenatal Testing (NIPT) Driven by the Adoption of Next Generation Sequencing (NGS) Techniques for Screening is Driving Market Growth

FEATURED COMPANIES

  • Ariosa Diagnostics
  • CombiMatrix
  • Counsyl
  • Integrated Genetics
  • LifeCodexx
  • Natera
  • MORE

Prenatal genetic tests are predominantly used to test disorders such as aneuploidies in chromosomes 21, 18, 13 and carrier screens. They are gaining momentum in EU due to enhanced assay outcomes through non-invasive methodologies using next generation sequencing (NGS) techniques, increasing number of women choosing to undergo pregnancy at an advanced maternal age (over 35 years) and considerable popularity through social media and e-commerce channels. High level of merger and acquisition activity apart from numerous collaborations with regional clinical labs has supported the participants in marketing their products across the European region.

Moreover, companies are also exploring new avenues to market their product by strategically tying up with IVF clinics, physicians, genetic counsellors and OBGYNs. Partnership with big data companies is anticipated to be the next big leap in the prenatal genetic testing market, thereby providing interpretation of vast volumes of data to increase specificity, sensitivity, and cost of tests. The key business model emerging across the market is the collaboration of key participants with regional private clinical labs as well as public centres and organizations such as NHS to increase the market coverage in Europe.

Research Scope

The key objectives of this growth insights study are to track the transformations in the prenatal genetic test market landscape in Europe for 2016-2021. The study aims at identifying growth opportunities across the market and suggesting most profitable business models to market players. Furthermore, the study provides an in-depth revenue and market analysis of 4 key segments within the prenatal landscape: NIPT, carrier screening for cystic fibrosis, invasive tests, and miscarriage tests. The study highlights industry challenges, growth drivers, restraints, competitive developments, key mergers and acquisitions (M&As), and investment opportunities. Key trends across the market with respect to physician and patient attitudes toward prenatal genetic screening and its probable impact on growth are analyzed. Additionally, top growth opportunities, profiles of game-changing companies, disruptive technologies and innovative business models, along with strategic recommendations are included.

Key Issues Addressed

  • Which are the most promising segments in the EU prenatal genetic testing market? Where is the most interest in terms of funding and innovation?
  • What are the most favorable business models across the prenatal testing market in Europe? How are companies coping with the market drawbacks and needs?
  • What are some of the most disruptive products in this market? Who are the key players in the market?
  • What are the gaps in the market that encourage penetration and provide opportunities to new entrants?
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Ariosa Diagnostics
  • CombiMatrix
  • Counsyl
  • Integrated Genetics
  • LifeCodexx
  • Natera
  • MORE

1. EXECUTIVE DASHBOARD

  • Purpose of This Experiential Study
  • 5-Step Process to Transformational Growth
  • Scope and Segmentation
  • Overview of Segments
  • Market Engineering Measurements
  • Key Questions Addressed in this Study

2. GROWTH ENVIRONMENT - MARKET OVERVIEW

  • Methodology
  • Key Findings - A Highly Consolidated Market
  • Market Dynamics - Steady but Strong Growth
  • Comparison with the US Market
  • Impact Analysis - Key Growth Contributors
  • Prevalence of Foetal Chromosomal Aneuploidies
  • Regulatory Landscape - Most Promising Markets
  • Termination of Pregnancy Laws - Regional Variations
  • Drivers and Restraints - Technology Driven Market
  • Key Market Challenges

3. GROWTH ENVIRONMENT - MARKET FORECASTS

  • Market Engineering Measurements
  • Revenue Forecast Assumptions
  • Revenue Forecast
  • Revenue Forecast Discussion
  • Market Share by Type of Prenatal Genetic Tests

4. GROWTH ENVIRONMENT - COMPETITIVE PLAYBOOK

  • Emerging Business Models
  • Competitive Factors and Assessment
  • Key Mergers & Acquisitions and Partnerships

5. GROWTH ENVIRONMENT - NON-INVASIVE PRENATAL TESTING MARKET

  • Segment Overview
  • Revenue Forecast Assumptions
  • Revenue Forecast
  • Revenue Forecast Discussion
  • Snapshot of Key Market Participants

6. GROWTH ENVIRONMENT - CARRIER SCREENING TESTS FOR CYSTIC FIBROSIS MARKET

  • Segment Overview
  • Revenue Forecast Assumptions
  • Revenue Forecast
  • Revenue Forecast Discussion
  • Snapshot of Key Market Participants

7. GROWTH ENVIRONMENT - INVASIVE PRENATAL TESTING MARKET

  • Segment Overview
  • Revenue Forecast Assumptions
  • Revenue Forecast
  • Revenue Forecast Discussion
  • Snapshot of Key Market Participants

8. GROWTH ENVIRONMENT - MISCARRIAGE TESTING MARKET

  • Segment Overview
  • Revenue Forecast Assumptions
  • Revenue Forecast
  • Revenue Forecast Discussion
  • Snapshot of Key Market Participants

9. VISIONING SCENARIOS

  • Macro to Micro Visioning
  • Trend Analysis in Prenatal Genetic Testing Market

10. GROWTH ENVIRONMENT AND COMPANIES TO ACTION

  • Transformation in Industry Eco-system
  • Strategic Imperatives for Market Growth
  • 5 Major Growth Opportunities
  • Growth Opportunity Matrix

11. THE LAST WORD

  • Top Predictions for the EU Prenatal Genetic Testing Market
  • Legal Disclaimer

12. APPENDIX

  • Abbreviations and Acronyms Used
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Ariosa Diagnostics
  • CombiMatrix
  • Counsyl
  • Integrated Genetics
  • LifeCodexx
  • Natera
  • Premaitha Health
  • Quest Diagnostics
  • Sequenom
  • Verinata Health
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll